News | July 27, 2025
Sigachi Industries reports Q1 FY26 consolidated loss at Rs. 100.35 Cr
Sigachi Industries has reported total income of Rs. 132.18 crores during the period ended June 30, 2025
Sigachi Industries has reported total income of Rs. 132.18 crores during the period ended June 30, 2025
Laurus Labs has reported total income of Rs. 1,580 crores during the period ended June 30, 2025
Solara Active Pharma Sciences has reported total income of Rs. 320.13 crores during the period ended June 30, 2025
_256_384.jpg)
Cipla has reported total income of Rs. 7,216.03 crores during the period ended June 30, 2025
RPG Life Sciences has reported total income of Rs. 174.15 crores during the period ended June 30, 2025
Reported EBITDA up by 19% year-on-year with reported EBITDA margin at 25%
Vimta Labs has reported total income of Rs. 99.31 crores during the period ended June 30, 2025
Apotex will also pay US$ 2.5 million upon receipt of final USFDA approval of the ANDA that is the subject of the Collaboration Agreement for Paclitaxel Protein-Bound Particles for Injectable Suspension
Operating income on consolidated basis increased by 38.10% at Rs 44.58 crore in Q4 FY25
Annual EBITDA margin expands by 170 basis points
Subscribe To Our Newsletter & Stay Updated
